Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Capital Bancorp
CBNK
$615M
| $10K | ﹤0.01% |
451
-845
| -65% | -$18.8K |
|
4427
Corvus Pharmaceuticals
CRVS
$1.17B
| $10K | ﹤0.01% |
9,671
-1,425
| -13% | -$1.75K |
|
4428
Digimarc Corp
DMRC
$178M
| $10K | ﹤0.01% |
686
-1,383
| -67% | -$28.5K |
|
4429
Dianthus Therapeutics
DNTH
$6.09B
| $10K | ﹤0.01% |
540
-287
| -35% | -$7.09K |
|
4430
State Street SPDR S&P International Dividend ETF
DWX
$533M
| $10K | ﹤0.01% |
300
| – | – |
|
4431
Destination XL Group
DXLG
$35.4M
| $10K | ﹤0.01% |
+2,999
| New | +$13.5K |
|
4432
EyePoint Inc
EYPT
$1.2B
| $10K | ﹤0.01% |
1,309
-2,737
| -68% | -$27.5K |
|
4433
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.83B
| $10K | ﹤0.01% |
72
| – | – |
|
4434
Full House Resorts
FLL
$89M
| $10K | ﹤0.01% |
1,649
-3,662
| -69% | -$28.2K |
|
4435
GrowGeneration
GRWG
$90.7M
| $10K | ﹤0.01% |
2,888
-6,366
| -69% | -$36.3K |
|
4436
Inspired Entertainment
INSE
$175M
| $10K | ﹤0.01% |
+1,111
| New | +$11.3K |
|
4437
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.45B
| $10K | ﹤0.01% |
+2,200
| New | +$15.3K |
|
4438
Liquidia Corp
LQDA
$8.02B
| $10K | ﹤0.01% |
+2,394
| New | +$12.4K |
|
4439
NerdWallet
NRDS
$652M
| $10K | ﹤0.01% |
+1,285
| New | +$13K |
|
4440
Pure Cycle
PCYO
$261M
| $10K | ﹤0.01% |
977
-2,150
| -69% | -$23.2K |
|
4441
Rigel Pharmaceuticals
RIGL
$750M
| $10K | ﹤0.01% |
866
-3,987
| -82% | -$80.1K |
|
|
SA
4442
Seabridge Gold
SA
$3.35B
| $10K | ﹤0.01% |
831
-259
| -24% | -$4.15K |
|
4443
Superior Group of Companies
SGC
$225M
| $10K | ﹤0.01% |
586
-1,321
| -69% | -$22.7K |
|
4444
Sight Sciences
SGHT
$412M
| $10K | ﹤0.01% |
1,081
-3,457
| -76% | -$30.4K |
|
4445
Target Hospitality
TH
$1.64B
| $10K | ﹤0.01% |
1,759
-2,290
| -57% | -$14.3K |
|
4446
Teekay
TK
$985M
| $10K | ﹤0.01% |
3,548
-7,772
| -69% | -$25.4K |
|
4447
TPG
TPG
$7.86B
| $10K | ﹤0.01% |
400
| – | – |
|
4448
Universal Logistics Holdings
ULH
$529M
| $10K | ﹤0.01% |
365
-881
| -71% | -$21K |
|
4449
Veritone
VERI
$122M
| $10K | ﹤0.01% |
1,569
-4,867
| -76% | -$49.1K |
|
4450
Village Super Market
VLGEA
$639M
| $10K | ﹤0.01% |
425
-959
| -69% | -$22.6K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.